Medpace Holdings Inc Stock
Medpace Holdings Inc Stock
There is an upward development for Medpace Holdings Inc compared to yesterday, with an increase of €8.10 (2.230%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Medpace Holdings Inc.
With a target price of 421 € there is a slightly positive potential of 15.5% for Medpace Holdings Inc compared to the current price of 364.5 €.
So far the community has only identified positive things for Medpace Holdings Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Medpace Holdings Inc in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medpace Holdings Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | 2.230% | 0.330% | 0.055% | 97.454% | 29.715% | 156.690% | - |
| Galapagos N.V. | -0.360% | 3.316% | -7.615% | -25.952% | -25.972% | -57.880% | - |
| Sage Therapeutics Inc. | -3.520% | -3.667% | -23.728% | -70.207% | -38.925% | -81.156% | - |
| Ironwood Pharmaceuticals | 6.210% | -3.333% | -8.805% | -22.043% | -28.922% | -21.622% | - |
Comments
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Guggenheim from $453.00 to $464.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $446.00 to $454.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $450.00 price target on the stock, up previously from $340.00.
Show more
Ratings data for MEDP provided by MarketBeat